Prior antiplatelet or anticoagulant therapy and mortality in stroke

Heart

Volumn 98, Issue 9, 2012, Pages 712-717

  Kwok, Chun Shing ^a   Skinner, Jane ^b   Metcalf, Anthony K ^a   Potter, John F ^a,b   Myint, Phyo Kyaw ^a,b,c  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; THROMBOSIS; UNIVERSITY HOSPITAL;

AGED; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STROKE; SURVIVAL RATE; TIME FACTORS;

EID: 84860154682     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301076     Document Type: Article

References (29)

1. Algra A, de Schryver EL, van Gijn J, et al. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Cochrane Database Syst Rev 2001;(4): CD001342.
2. Simmons BB, Yeo A, Fung K; American Heart Association; American Stroke Association. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review. Postgrad Med 2010;122:49-53.
3. Diener HC. Primary and secondary prevention of stroke with antiplatelet agents. Curr Pharm Des 2006;12:1293-7.
4. O'Rouke F, Dean N, Akhtar N, et al. Current and future concepts in stroke prevention. CMAJ 2004;170:1123-33. (Pubitemid 38446402)
5. Sanossian N, Saver JL, Rajajee V, et al. Premorbid antiplatelet use and ischaemic stroke outcomes. Neurology 2006;66:3109-23.
6. Wilterdink JL, Bendixen B, Adams HP Jr, et al. Effect of prior aspirin use on stroke severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke 2001;32:2836-40. (Pubitemid 33134475)
7. Foerch C, Sitzer M, Steinmetz H, et al. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral haemorrhage. Stroke 2006;37:2165-7. (Pubitemid 44309922)
8. Thompson BB, Bejot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral haemorrhage: a systematic review. Neurology 2010;75:1333-42.
9. Myint PK, Vowler SL, Woodhouse PR, et al. Winter excess in hospital admission, inpatient mortality and length of acute hospital stay in stroke: a hospital database study over six seasonal years in Norfolk, UK. Neuroepidemiology 2007;28:79-85. (Pubitemid 46633196)
10. Farrell B, Godwin J, Richards S, et al. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044-54.
11. Myint PK, Sankaran P, Musonda P, et al. Performance of CURB-65 and CURB-age in community-acquired pneumonia. Int J Clin Pract 2009;63:1345-50.
12. Saloheimo P, Ahonen M, Juvela S, et al. Regular aspirin-use preceding the onset of primary intracerebral haemorrhage is an independent predictor of death. Stroke 2006;37:129-33. (Pubitemid 43732060)
13. Toyoda K, Okada Y, Minematsu K, et al. Antiplatelet therapy contributes to acute deterioration in intracerebral haemorrhage. Neurology 2005;65:1000-4. (Pubitemid 41429621)
14. Sansing LH, Messe SR, Cucchiara BL, et al CHANT Investigators. Prior antiplatelet use does not affect haemorrhage growth or outcome after ICH. Neurology 2009;72:1397-402.
15. de Gans de, Haan RJ, Majoie CB, et al; PATCH Investigators. PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol 2010;10:19.
16. The ACTIVE Writing Group. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet 2006;367:1903-12.
17. Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischaemic attack. Cochrane Database Syst Rev 2007;(3): CD006186.
18. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al German Stroke Registers Study Group. Predictors of in-hospital mortality and attributable risks of death after ischaemic stroke. Arch Intern Med 2004;164:1761-8. (Pubitemid 39215645)
19. Palm F, Urbanek C, Rose S, et al. Stroke incidence and survival in Ludwigshafen am Rhein, Germany: the Ludwigshafen Stroke Study (LuSSt). Stroke 2010;41:1865-70.
20. Greisenegger S, Tentschert S, Weber M, et al. Prior therapy with antiplatelet agents is not associated with outcome in patients with acute ischaemic stroke/TIA. J Neurol 2006;253:648-52. (Pubitemid 43876997)
21. Dowlatshahi D, Hakim A, Fang J, et al Investigators of the Registry of the Canadian Stroke Network. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network. Int J Stroke 2009;4:328-34.
22. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral haemorrhage growth: an exploratory analysis. Stroke 2007;38:1072-5. (Pubitemid 46568477)
23. Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr, et al. Prior antiplatelet therapy platelet infusion therapy and outcome after intracerebral haemorrhage. J Stroke Cerebrovasc Dis 2009;18:221-8.
24. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinical identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-6.
25. Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral haemorrhage. Arch Intern Med 2004;164:880-4. (Pubitemid 38520629)
26. Goldstein JN, Thomas SH, Frontiero V, et al. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral haemorrhage. Stroke 2006;37:151-5. (Pubitemid 43732064)
27. Hutter HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral haemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006;37:1465-70. (Pubitemid 44305727)
28. Lee SB, Manno EM, Layton KF, et al. Progression of warfarin-associated intracerebral haemorrhage after INR normalization with FFP. Neurology 2006;67:1272-4. (Pubitemid 44566354)
29. Hillborn ME, Juvela SS, Soinne L, et al. Platelet transfusion in acute intracerebral hemorrahge. http://clinicaltrials.gov/ct2/show/NCT00699621 (accessed 31 Jan 2012).